ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6,201 | 20.58899 | 0 | female | 0 | 13 | 1,739 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 12 | under $11k | 0 | 16,083 | 11,785.3828 | 11,721.6172 | 12 | black | 25.898438 | 48 | 0.899902 | 0.863892 | 1 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 13 | 83 | 12.298828 | 155 | 36 | 39 | 336 | 4.099609 | 0.599976 | 11.199219 | 135 | 7.349609 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
6,202 | 72.13696 | 1 | male | 0 | 18 | 253 | MOSF w/Malig | ARF/MOSF | 2 | 9 | under $11k | 0 | 25,015 | 17,548.375 | 18,899.9844 | 27.333328 | white | 36.09375 | 91 | 0.367981 | 0.250977 | 1 | 0 | 0 | yes | 0.3 | 0.05 | dnr after sadm | 5 | 62 | 0.25 | 108 | 23 | 38.09375 | 361.875 | 1.799805 | 10.898438 | 2.299805 | 140 | 7.329102 | null | null | null | 2 | 1 | no(M2 and SIP pres) | 1 |
6,203 | 66.77899 | 1 | male | 0 | 27 | 35 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 10 | null | 9 | 41,097 | 32,138.6406 | 30,246.6875 | 21.75 | white | 24.5 | 38 | 0.73291 | 0.649902 | 4 | 0 | 0 | no | 0.8 | 0.75 | no dnr | 27 | 114 | 4 | 120 | 34 | 37.79688 | 213.3125 | 2.199707 | 1.299805 | 0.799927 | 139 | 7.449219 | null | null | null | null | null | <2 mo. follow-up | 3.980469 |
6,204 | 61.37997 | 1 | female | 0 | 13 | 748 | COPD | COPD/CHF/Cirrhosis | 2 | 9 | under $11k | 0 | 17,195 | 13,187.8906 | 12,204.5859 | 26.5 | white | 28.296875 | 38 | 0.776978 | 0.643921 | 1 | 0 | 0 | no | 0.98 | 0.9 | no dnr | 13 | 154 | 8.599609 | 141 | 30 | 37.69531 | 150 | 3.099609 | 0.599976 | 0.599976 | 141 | 7.319336 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
6,205 | 56.392 | 0 | female | 0 | 4 | 1,736 | CHF | COPD/CHF/Cirrhosis | 4 | 9 | under $11k | 0 | 3,863 | 2,772.7852 | 2,513.41992 | 13 | black | 21.097656 | 21 | 0.875 | 0.791992 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 4 | 97 | 6.599609 | 114 | 24 | 35.39844 | 261.875 | null | 0.5 | 1.199951 | 136 | 7.449219 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
6,206 | 81.44598 | 1 | female | 1 | 15 | 15 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 10 | null | 44 | 63,753 | 44,092.0625 | 44,405.9062 | 44 | white | 34.5 | 65 | 0.169983 | 0.084991 | 13 | 0 | 0 | no | 0.2 | 0.1 | dnr after sadm | 1 | 73 | 29.898438 | 136 | 54 | 38.59375 | 186.25 | 2.299805 | 2.799805 | 0.699951 | 127 | 7.40918 | null | null | null | null | 6 | <2 mo. follow-up | 6 |
6,207 | 70.10498 | 1 | female | 0 | 16 | 418 | MOSF w/Malig | ARF/MOSF | 3 | 10 | $11-$25k | 0 | 15,832 | 11,012.5156 | 12,351.3125 | 20.333328 | white | 27.199219 | 50 | 0.543945 | 0.429993 | 1 | 0 | 0 | metastatic | 0.6 | 0.3 | no dnr | 16 | 65 | 0 | 74 | 22 | 35.79688 | 341.375 | 2.599609 | 3 | 1.099854 | 138 | 7.40918 | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
6,208 | 58.29398 | 0 | female | 0 | 11 | 1,733 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 44 | 10,777 | 8,412.125 | 7,989.67969 | 14 | black | 20.398438 | 19 | 0.767944 | 0.69397 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 11 | 103 | 9.699219 | 108 | 24 | 36.19531 | 376.1875 | 2.5 | 0.599976 | 0.599976 | 139 | 7.319336 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
6,209 | 51.29398 | 1 | female | 0 | 24 | 64 | Colon Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 17,845 | 13,605.9219 | 12,001.7188 | 16.666656 | hispanic | 50.695313 | 38 | 0.067993 | 0.001 | 1 | 0 | 0 | metastatic | 0.2 | 0.1 | no dnr | 24 | 69 | 11.898438 | 108 | 20 | 36.19531 | null | 1.799805 | 6.799805 | 0.699951 | 123 | null | null | null | null | 3 | 0 | null | 0 |
6,210 | 66.48895 | 1 | male | 0 | 8 | 351 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | under $11k | 0 | 12,177 | 9,755.1797 | 9,127.00781 | 13 | white | 22.597656 | 23 | 0.821899 | 0.761963 | 1 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 8 | 82 | 23.296875 | 111 | 24 | 36.19531 | 289.9375 | 3.899902 | 0.5 | 1.099854 | 132 | 7.25 | null | null | null | 0 | 1 | null | 1 |
6,211 | 52.28497 | 1 | male | 1 | 9 | 9 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | under $11k | 44 | 36,974 | 28,766.9219 | 27,441.1875 | 58.5 | white | 38 | 80 | 0.276978 | 0.168976 | 9 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 6 | 57 | 19.097656 | 103 | 43 | 35.69531 | 108.32812 | 1.799805 | 4.5 | 1.099854 | 131 | 7.319336 | null | null | null | null | 6 | <2 mo. follow-up | 6 |
6,212 | 93.008 | 0 | female | 0 | 5 | 1,731 | CHF | COPD/CHF/Cirrhosis | 2 | 0 | under $11k | 0 | 3,541 | 2,628.5019 | 2,532.08984 | 16 | white | 17.796875 | 39 | 0.793945 | 0.667969 | 1 | 0 | 0 | no | 0.9 | 0.8 | dnr before sadm | -1 | 98 | 4.799805 | 110 | 28 | 36.29688 | 329.5 | 4.399414 | 1.099854 | 1.899902 | 138 | 7.379883 | null | null | null | null | null | no(M2 and SIP pres) | 3.304199 |
6,213 | 69.24597 | 1 | male | 1 | 11 | 11 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 8 | $11-$25k | 0 | 47,436 | 33,556.7812 | 33,853.0938 | 52 | white | 27.699219 | 48 | 0.670898 | 0.575928 | 1 | 0 | 0 | yes | 0.5 | 0.5 | dnr after sadm | 10 | 119 | 2.199707 | 73 | 10 | 36.5 | 214 | 1.899902 | 0.799927 | 4.599609 | 136 | 7.369141 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
6,214 | 54.92999 | 1 | female | 0 | 29 | 430 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | $25-$50k | 0 | 42,297 | 33,734.9062 | 30,732.0469 | 32.75 | white | 32.695313 | 64 | 0.699951 | 0.609985 | 1 | 1 | 0 | no | 0.8 | 0.8 | no dnr | 29 | 103 | 12.898438 | 104 | 40 | 39.29688 | 127.26562 | 2.099609 | 0.199982 | 6 | 135 | 7.349609 | null | null | null | null | 5 | no(M2 and SIP pres) | 5 |
6,215 | 73.55499 | 1 | male | 0 | 35 | 421 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | null | null | 9 | 38,373 | 29,278 | 26,472.5781 | 18.75 | white | 19.398438 | 34 | 0.776978 | 0.704956 | 1 | 0 | 1 | yes | 0.7 | 0.6 | no dnr | 35 | 68 | 22.398438 | 77 | 29 | 37.79688 | 210.46875 | 2.299805 | 0.299988 | 1.799805 | 145 | 7.419922 | null | null | null | null | null | null | 5.741211 |
6,216 | 73.72198 | 1 | female | 0 | 10 | 168 | CHF | COPD/CHF/Cirrhosis | 4 | 8 | null | 0 | 6,401 | 4,831.8086 | 4,294.50781 | 12 | black | 17.898438 | 32 | 0.858887 | 0.766968 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 10 | 71 | null | 66 | 26 | 36.5 | null | null | 0.899902 | 1.599854 | 139 | null | null | null | null | null | 4 | null | 4 |
6,217 | 84.08496 | 1 | male | 0 | 3 | 728 | CHF | COPD/CHF/Cirrhosis | 2 | 4 | under $11k | 0 | 1,705 | 1,299.8232 | 1,272.21973 | 10 | white | 15.599609 | 26 | 0.852905 | 0.757935 | 1 | 0 | 0 | no | 0.95 | 0.7 | no dnr | 3 | 82 | 8.199219 | 76 | 32 | 36.5 | 323.75 | 3.399902 | 0.599976 | 1.199951 | 139 | 7.429688 | null | null | null | null | null | no(M2 and SIP pres) | 2.624512 |
6,218 | 89.52496 | 0 | female | 0 | 15 | 1,725 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 10 | null | 9 | 20,729 | 16,369.9453 | 14,905.6562 | 15 | white | 21.097656 | 43 | 0.674927 | 0.579956 | 1 | 0 | 0 | yes | 0.5 | 0.3 | no dnr | 15 | 62 | 8.599609 | 66 | 26 | 36 | 327.625 | 2.699707 | 1.199951 | 2.199707 | 140 | 7.359375 | null | null | null | null | null | null | 4.146484 |
6,219 | 34.53299 | 1 | male | 0 | 10 | 708 | Cirrhosis | COPD/CHF/Cirrhosis | 4 | 13 | null | 0 | 16,270 | 12,321.6016 | 12,486.2344 | 25.5 | white | 30.898438 | 25 | 0.766968 | 0.628906 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 10 | 71 | 11.5 | 51 | 24 | 36.19531 | 102.84375 | 3.099609 | 2.699707 | 0.5 | 136 | 7.489258 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
6,220 | 45.103 | 1 | male | 1 | 3 | 3 | Cirrhosis | COPD/CHF/Cirrhosis | 4 | null | null | 100 | 13,521 | 9,469.1875 | 10,395.1953 | 65 | white | 66.390625 | 102 | 0 | 0 | 1 | 0 | 0 | no | null | null | dnr after sadm | 3 | 33 | 15.099609 | 0 | 30 | 37.79688 | 88.09375 | 2.199707 | 6.5 | 3.699707 | 154 | 7.069336 | null | null | null | null | null | <2 mo. follow-up | 3.754883 |
6,221 | 26.75699 | 0 | female | 0 | 18 | 1,722 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | >$50k | 41 | 34,571 | 24,394.75 | 24,727 | 32 | white | 20.699219 | 23 | 0.868896 | 0.822998 | 1 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 18 | 80 | 19.898438 | 139 | 24 | 38 | 255.96875 | 1.799805 | 1.399902 | 0.799927 | 138 | 7.399414 | null | null | null | null | 0 | SIP>=30 | 0 |
6,222 | 83.31299 | 1 | male | 0 | 4 | 560 | CHF | COPD/CHF/Cirrhosis | 5 | 12 | under $11k | 0 | 2,717 | 1,988.3877 | 1,975.83984 | 14 | white | 16.796875 | 28 | 0.802979 | 0.681885 | 1 | 0 | 0 | yes | 0.8 | 0.5 | no dnr | 4 | 115 | 5.899414 | 66 | 28 | 35 | 368.5625 | 3.899902 | 0.699951 | 1.099854 | 139 | 7.429688 | null | null | null | null | null | no(M2 and SIP pres) | 3.341797 |
6,223 | 64.45398 | 1 | female | 0 | 7 | 972 | CHF | COPD/CHF/Cirrhosis | 4 | 11 | under $11k | 0 | 5,484 | 4,037.291 | 4,067.18945 | 17 | white | 17.699219 | 21 | 0.855957 | 0.762939 | 1 | 1 | 0 | yes | 0.95 | 0.9 | no dnr | 7 | 96 | 6 | 65 | 22 | 36.19531 | 390.4375 | null | 0.599976 | 1.699951 | 137 | 7.459961 | null | null | null | 1 | 1 | no(M2 and SIP pres) | 1 |
6,224 | 58.87997 | 1 | female | 1 | 41 | 41 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 16 | $11-$25k | 0 | 98,466 | 74,373.6875 | 72,003.625 | 43.5 | white | 28.296875 | 56 | 0.707886 | 0.619995 | 7 | 1 | 0 | no | 0.05 | 0.000125 | no dnr | 41 | 60 | 26.898438 | 125 | 24 | 38.19531 | 445.9375 | 2.399902 | 1.599854 | 7.299805 | 130 | 7.459961 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
6,225 | 65.172 | 0 | female | 0 | 14 | 1,719 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 10 | under $11k | 26 | 19,606 | 15,423.0078 | 14,428.4688 | 24.666656 | white | 18.796875 | 25 | 0.80188 | 0.735962 | 2 | 1 | 0 | no | 0.8 | 0.7 | no dnr | 14 | 70 | 12.199219 | 74 | 32 | 36.39844 | 385.6875 | 2.599609 | 0.799927 | 1.399902 | 145 | 7.379883 | null | null | null | null | 7 | adl>=4 (>=5 if sur) | 7 |
6,226 | 64.69299 | 1 | female | 0 | 14 | 1,099 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | under $11k | 0 | 64,100 | 49,874.6562 | 49,526.7188 | 19.333328 | white | 31.296875 | 47 | 0.583984 | 0.474976 | 17 | 0 | 0 | no | 0.98 | 0.97 | no dnr | 14 | 79 | 16.898438 | 54 | 36 | 36.19531 | 296 | null | null | 5.5 | 129 | 7.419922 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
6,227 | 35.461 | 1 | male | 0 | 42 | 61 | MOSF w/Malig | ARF/MOSF | 2 | 12 | under $11k | 0 | 55,640 | 37,463.4375 | 40,091.8125 | 30.5 | black | 27.097656 | 41 | 0.67395 | 0.578979 | 1 | 0 | 0 | yes | 0.1 | 0.001 | dnr after sadm | 32 | 80 | 23.097656 | 128 | 40 | 40.09375 | 319 | 2.299805 | 1.099854 | 1.099854 | 131 | 7.469727 | null | null | null | null | 0 | null | 0 |
6,228 | 80.88696 | 1 | male | 1 | 9 | 9 | Coma | Coma | 1 | 8 | $11-$25k | 100 | 14,939 | 12,200.5156 | 11,065.7578 | 33.5 | white | 35.695313 | 50 | 0.002 | 0 | 1 | 0 | 0 | no | 0.05 | 0.000125 | dnr after sadm | 1 | 131 | 19.5 | 126 | 10 | 38.09375 | 58 | null | 6 | 1.099854 | 147 | 7.339844 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
6,229 | 67.47699 | 1 | male | 1 | 17 | 17 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 12 | null | 41 | 50,465 | 33,040.4062 | 33,490.7812 | 49.333313 | white | 34.398438 | 52 | 0.241974 | 0.139984 | 4 | 1 | 0 | yes | 0.1 | 0.001 | dnr after sadm | 17 | 54 | 9.898438 | 103 | 24 | 36.39844 | 129 | 2.799805 | 4.599609 | 1.599854 | 133 | 7.439453 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
6,230 | 26.752 | 1 | female | 1 | 22 | 22 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 0 | 46,415 | 36,414.0938 | 34,510 | 26.333328 | white | 22.898438 | 30 | 0.887939 | 0.8479 | 1 | 0 | 0 | yes | 0.95 | 0.9 | no dnr | 22 | 62 | 6.099609 | 131 | 22 | 38.79688 | 376.1875 | 2 | 0.299988 | 0.399963 | 134 | 7.389648 | null | null | null | 4 | null | <2 mo. follow-up | 3.183199 |
6,231 | 64.34796 | 1 | female | 1 | 27 | 27 | MOSF w/Malig | ARF/MOSF | 1 | 11 | under $11k | 0 | null | null | null | 31.5 | white | 24 | 32 | 0.573975 | 0.462952 | 5 | 0 | 0 | metastatic | 0.9 | 0.9 | null | null | 63 | 13 | 122 | 28 | 38.09375 | 176 | 2.699707 | 0.299988 | 0.799927 | 138 | 7.429688 | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
6,232 | 61.62598 | 1 | male | 0 | 9 | 334 | MOSF w/Malig | ARF/MOSF | 1 | 17 | $25-$50k | 0 | 7,240 | 5,208.207 | 5,493.56641 | 15 | white | 22 | 38 | 0.740967 | 0.660889 | 1 | 0 | 0 | yes | 0.8 | 0.7 | no dnr | 9 | 70 | 0.219971 | 80 | 22 | 37.79688 | null | 2.199707 | 1.099854 | 1.199951 | 136 | null | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
6,233 | 57.771 | 0 | male | 0 | 285 | 1,717 | COPD | COPD/CHF/Cirrhosis | 4 | 8 | under $11k | 0 | 344,593 | 228,765.125 | 222,052 | 33.5 | white | 23.597656 | 28 | 0.859985 | 0.767944 | 1 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 285 | 114 | 9.398438 | 124 | 27 | 37.69531 | 206.4375 | 3.099609 | 1.399902 | 1.099854 | 137 | 7.40918 | null | null | null | 6 | 6 | adl>=4 (>=5 if sur) | 6 |
6,234 | 68.06598 | 1 | male | 1 | 5 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 6 | null | 61 | 38,804 | 26,502.6562 | 26,784 | 60 | white | 37.195313 | 90 | 0.126984 | 0.056999 | 8 | 0 | 0 | no | null | null | dnr after sadm | 5 | 59 | 39 | 103 | 38 | 39.19531 | 166 | 2 | 10 | 6 | 141 | 7.419922 | null | null | null | null | 6 | <2 mo. follow-up | 6 |
6,235 | 48.35898 | 1 | female | 1 | 14 | 14 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 7 | under $11k | 0 | 50,534 | 40,139.25 | 37,470.5312 | 47.333313 | white | 45.195313 | 67 | 0.345947 | 0.228973 | 5 | 1 | 0 | no | 0.1 | 0.001 | no dnr | 14 | 43 | 11.199219 | 164 | 36 | 39.79688 | 89 | 2.399902 | 1.899902 | 0.699951 | 137 | 7.389648 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
6,236 | 61.284 | 1 | male | 0 | 10 | 129 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 7,160 | 5,280.0586 | 5,089.54688 | 10.5 | white | 19.097656 | 19 | 0.879883 | 0.800903 | 1 | 0 | 0 | no | 0.6 | 0.4 | dnr after sadm | 1 | 81 | 14.099609 | 70 | 25 | 36.39844 | null | 3.599609 | 0.899902 | 1 | 131 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
6,237 | 54.86899 | 1 | male | 0 | 32 | 1,050 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 13 | null | 0 | 43,079 | 31,790.9688 | 31,851.75 | 29.5 | white | 32.398438 | 36 | 0.705933 | 0.616943 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 32 | 48 | 27 | 118 | 10 | 36.39844 | 260 | 2.799805 | 4.299805 | 1.199951 | 140 | 7.359375 | null | null | null | null | 6 | adl>=4 (>=5 if sur) | 6 |
6,238 | 55.86298 | 1 | male | 0 | 6 | 136 | Colon Cancer | Cancer | 1 | 12 | $11-$25k | 26 | 5,997 | 4,148.6406 | 5,896.27734 | 8 | white | 13.798828 | 13 | 0.814941 | 0.601929 | 1 | 0 | 0 | metastatic | 0.8 | 0.7 | no dnr | 6 | 103 | 8.599609 | 60 | 20 | 36.5 | null | 3.699707 | 0.299988 | 0.699951 | 139 | null | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
6,239 | 29.05699 | 1 | female | 0 | 7 | 61 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 3 | under $11k | 61 | 8,497 | 6,915.5156 | 6,116.02734 | 41 | black | 35.195313 | 59 | 0.444946 | 0.324951 | 1 | 0 | 0 | yes | 0.5 | 0.5 | dnr after sadm | 1 | 57 | 22.597656 | 164 | 72 | 38.39844 | 288.3125 | 3.699707 | 0.599976 | 0.399963 | 125 | 7.459961 | null | null | null | null | 7 | null | 7 |
6,240 | 55.27399 | 1 | male | 1 | 3 | 3 | Coma | Coma | 2 | 12 | null | 100 | 7,765 | 5,475.0547 | 5,630.63672 | 33 | white | 41.296875 | 73 | 0.004999 | 0.002 | 2 | 1 | 0 | no | 0 | 0 | dnr after sadm | 2 | 58 | 12.798828 | 30 | 22 | 41.69531 | 127.14062 | null | 2.899902 | 3.399902 | 134 | 7.389648 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
6,241 | 33.57999 | 1 | female | 1 | 4 | 4 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 55 | 31,600 | 24,093.25 | 25,462.5312 | 34 | white | 39.195313 | 63 | 0.039993 | 0.011999 | 18 | 0 | 0 | yes | 0.1 | 0.001 | dnr after sadm | 2 | 58 | 20.097656 | 157 | 43 | 36.39844 | 46 | 2.599609 | 1.099854 | 0.599976 | 144 | 7.25 | null | null | null | null | null | <2 mo. follow-up | 2.935547 |
6,242 | 45.89697 | 1 | male | 0 | 13 | 54 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 10,048 | 7,389.8828 | 7,053.45703 | 8 | white | 31.597656 | 38 | 0.67395 | 0.50293 | 1 | 1 | 0 | no | 0.5 | 0.3 | no dnr | 13 | 73 | 10.898438 | 104 | 22 | 36.79688 | null | 2.799805 | 29.296875 | 1 | 130 | null | null | null | null | null | null | <2 mo. follow-up | 3.974121 |
6,243 | 38.83398 | 1 | female | 0 | 6 | 55 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 4,638 | 3,372.1992 | 4,242.41797 | 10 | black | 33 | 48 | 0.699951 | 0.536987 | 1 | 0 | 0 | no | 0.5 | 0.4 | no dnr | 6 | 63 | 8.898438 | 60 | 15 | 35.59375 | 421.375 | 2.099609 | 17.296875 | 0.399963 | 128 | 7.389648 | null | null | null | 7 | 2 | <2 mo. follow-up | 2 |
6,244 | 55.37 | 0 | male | 0 | 11 | 1,710 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 8 | $11-$25k | 0 | 8,763 | 6,394.5742 | 6,287.38672 | 13.5 | white | 29.398438 | 60 | 0.645996 | 0.465942 | 1 | 0 | 0 | no | 0.9 | 0.75 | no dnr | 11 | 54 | 13.599609 | 74 | 28 | 38.19531 | 297.5625 | 2.399902 | 17.296875 | 0.699951 | 133 | 7.5 | null | null | null | null | null | no(M2 and SIP pres) | 3.67041 |
6,245 | 55.34299 | 1 | male | 0 | 4 | 131 | Colon Cancer | Cancer | 2 | 12 | $11-$25k | 0 | 2,774 | 2,039.4951 | 2,042.26953 | 8 | white | 29.398438 | 24 | 0.608887 | 0.291992 | 1 | 1 | 0 | metastatic | 0.4 | 0.3 | no dnr | 4 | 120 | 5.599609 | 134 | 20 | 38.19531 | null | 2.799805 | 0.799927 | 1 | 132 | null | null | null | null | 2 | null | no(M2 and SIP pres) | 1.839 |
6,246 | 58.81998 | 1 | male | 0 | 3 | 68 | Lung Cancer | Cancer | 2 | 10 | under $11k | 0 | 2,551 | 1,671.3389 | 1,856.75 | 11 | black | 18.5 | 14 | 0.692993 | 0.403992 | 1 | 1 | 0 | metastatic | null | null | no dnr | 3 | 95 | 12.398438 | 86 | 21 | 35.19531 | null | 3.599609 | 0.5 | 0.699951 | 141 | null | null | null | null | null | null | no(M2 and SIP pres) | 2.67627 |
6,247 | 51.50198 | 1 | female | 0 | 42 | 446 | Coma | Coma | 0 | 11 | under $11k | 55 | 52,344 | 39,543.2812 | 37,939.1562 | 29.25 | black | 30.398438 | 60 | 0.358948 | 0.28595 | 2 | 0 | 0 | no | 0.2 | 0.1 | no dnr | 42 | 109 | 22.097656 | 66 | 30 | 36.09375 | 319.625 | 1.599854 | 4.5 | 3.5 | 133 | 7.359375 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
6,248 | 55.51797 | 1 | male | 0 | 22 | 156 | COPD | COPD/CHF/Cirrhosis | 4 | 12 | under $11k | 0 | 24,343 | 16,756.9375 | 15,828.2344 | 12.333328 | white | 28.097656 | 48 | 0.786987 | 0.658936 | 4 | 0 | 0 | no | 0.9 | 0.7 | no dnr | 22 | 121 | 26.699219 | 150 | 56 | 36.09375 | 259.25 | null | null | 0.899902 | 136 | 7.419922 | null | null | null | null | null | no(M2 and SIP pres) | 4.519531 |
6,249 | 70.41998 | 1 | male | 0 | 10 | 280 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | under $11k | 26 | 8,446 | 5,952.4453 | 5,405.47656 | 13 | white | 17.699219 | 28 | 0.812988 | 0.750977 | 1 | 0 | 0 | no | 0.98 | 0.95 | dnr after sadm | 1 | 131 | 11.398438 | 84 | 28 | 37.19531 | 277.8125 | 3.699707 | 0.299988 | 0.699951 | 136 | 7.289062 | null | null | null | null | 6 | adl>=4 (>=5 if sur) | 6 |
6,250 | 65.08997 | 1 | female | 0 | 15 | 71 | MOSF w/Malig | ARF/MOSF | 1 | 10 | $11-$25k | 0 | 19,519 | 15,068.7812 | 14,244.6641 | 21.666656 | white | 20.699219 | 19 | 0.703979 | 0.61499 | 1 | 0 | 0 | metastatic | 0.1 | 0.001 | no dnr | 15 | 115 | 7.199219 | 113 | 14 | 36.09375 | 286.625 | 2.699707 | 1 | 1.199951 | 133 | 7.509766 | null | null | null | null | 2 | SIP>=30 | 2 |
6,251 | 25.69699 | 1 | male | 0 | 8 | 891 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | under $11k | 0 | 12,994 | 10,274.8672 | 9,332.03906 | 22.5 | white | 26.796875 | 53 | 0.865967 | 0.81897 | 3 | 1 | 0 | no | 0.95 | 0.95 | no dnr | 8 | 100 | 15 | 78 | 24 | 36.39844 | 404 | 3.199707 | 3.399902 | 7.899414 | 129 | 7.349609 | null | null | null | 0 | 0 | SIP>=30 | 0 |
6,252 | 70.14099 | 1 | male | 0 | 3 | 76 | Lung Cancer | Cancer | 2 | 14 | $11-$25k | 0 | 2,942 | 1,867.9678 | 2,097.55859 | 13 | white | 17.597656 | 9 | 0.68396 | 0.389954 | 1 | 0 | 0 | metastatic | 0.6 | 0.15 | no dnr | 3 | 94 | 14.5 | 86 | 20 | 36.59375 | null | 3.299805 | 0.5 | 0.899902 | 139 | null | null | null | null | 0 | 0 | SIP>=30 | 0 |
6,253 | 56.34198 | 1 | male | 0 | 25 | 226 | MOSF w/Malig | ARF/MOSF | 2 | 16 | $25-$50k | 0 | 49,663 | 33,070.1875 | 36,967.2188 | 29 | white | 36.796875 | 40 | 0.303955 | 0.191986 | 5 | 1 | 0 | yes | 0.75 | 0.4 | no dnr | 25 | 105 | 0.299988 | 122 | 22 | 36 | null | 3.099609 | 1.599854 | 0.899902 | 124 | null | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
6,254 | 74.33496 | 0 | male | 0 | 5 | 1,703 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 5,459 | 4,383.8945 | 3,989.73828 | 13 | white | 14.398438 | 16 | 0.879883 | 0.800903 | 1 | 0 | 0 | no | 0.9 | 0.5 | no dnr | 5 | 117 | 15 | 70 | 24 | 36 | 261.1875 | 4 | 0.599976 | 0.799927 | 141 | 7.389648 | null | null | null | 2 | 4 | no(M2 and SIP pres) | 4 |
6,255 | 69.37994 | 1 | female | 0 | 20 | 1,171 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 14 | $11-$25k | 0 | 18,470 | 13,978.9375 | 14,605.5078 | 12.333328 | white | 24.296875 | 38 | 0.571899 | 0.376953 | 1 | 1 | 0 | yes | 0.9 | 0.5 | no dnr | 20 | 71 | 9.5 | 107 | 20 | 36.79688 | null | 1.899902 | 3.5 | 0.699951 | 129 | null | null | null | null | 0 | 0 | SIP>=30 | 0 |
6,256 | 65.36298 | 1 | female | 0 | 8 | 365 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 5,975 | 4,376.9805 | 4,099.86719 | 7 | white | 14.398438 | 22 | 0.908936 | 0.846924 | 1 | 1 | 0 | no | 0.7 | 0.5 | dnr after sadm | 2 | 71 | 8.5 | 82 | 20 | 36.5 | 266.625 | null | 0.899902 | 1 | 135 | 7.509766 | null | null | null | 4 | 0 | no(M2 and SIP pres) | 0 |
6,257 | 50.97299 | 1 | male | 0 | 13 | 1,258 | CHF | COPD/CHF/Cirrhosis | 4 | 0 | under $11k | 0 | 9,679 | 7,019.1406 | 6,948.99609 | 13.5 | black | 18.199219 | 28 | 0.909912 | 0.8479 | 1 | 0 | 0 | no | 0.9 | 0.75 | no dnr | 13 | 76 | 7.399414 | 68 | 20 | 36.79688 | 228.09375 | 2.799805 | 0.099991 | 1 | 134 | 7.429688 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
6,258 | 59.18698 | 1 | male | 1 | 6 | 6 | Lung Cancer | Cancer | 2 | 11 | under $11k | 0 | 4,981 | 3,580.6914 | 3,540.37891 | 13 | white | 20.097656 | 19 | 0.655884 | 0.35199 | 1 | 0 | 0 | metastatic | 0.5 | 0.1 | dnr after sadm | 1 | 76 | 7.699219 | 112 | 24 | 36 | 371.375 | 3.399902 | 0.699951 | 1 | 140 | 7.369141 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
6,259 | 79.88794 | 1 | male | 1 | 70 | 70 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 12 | under $11k | 0 | 235,460 | 167,200.875 | 163,063.625 | 46 | white | 27.398438 | 38 | 0.490967 | 0.372986 | 73 | 0 | 0 | yes | 0.5 | 0.3 | dnr after sadm | 65 | 73 | 5.599609 | 121 | 29 | 36.79688 | 200 | 2.599609 | 1.099854 | 1.799805 | 134 | 7.369141 | null | null | null | null | 7 | adl>=4 (>=5 if sur) | 7 |
6,260 | 40.62698 | 0 | male | 0 | 21 | 1,697 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 62,342 | 45,183.9688 | 44,790.0312 | 44.666657 | white | 26.597656 | 27 | 0.809937 | 0.746948 | 7 | 0 | 0 | no | null | null | no dnr | 21 | 105 | 15.298828 | 100 | 12 | 36.5 | 165.6875 | 2.399902 | 3.899902 | 1.099854 | 132 | 7.419922 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
6,261 | 79.05298 | 0 | female | 0 | 26 | 1,697 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 9 | 40,883 | 29,752.3906 | 27,120.9375 | 22.5 | white | 19.398438 | 30 | 0.738892 | 0.656982 | 14 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 26 | 72 | 16.199219 | 73 | 24 | 35.79688 | 212.5 | 1.599854 | 1.299805 | 0.799927 | 136 | 7.299805 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
6,262 | 56 | 0 | female | 0 | 34 | 1,697 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 0 | 71,478 | 49,773.9375 | 48,391.8438 | 28.25 | white | 16.097656 | 20 | 0.882935 | 0.840942 | 9 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 34 | 71 | 22.699219 | 73 | 28 | 38.09375 | 278.8125 | null | null | 0.899902 | 139 | 7.459961 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
6,263 | 51.23099 | 1 | female | 1 | 4 | 4 | MOSF w/Malig | ARF/MOSF | 2 | 10 | under $11k | 9 | 7,038 | 5,127.2344 | 5,151.40625 | 48 | black | 50.796875 | 67 | 0.014 | 0.003 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 3 | 35 | 22.097656 | 55 | 4 | 36 | 75.32812 | 3 | 0.399963 | 0.5 | 138 | 7.189453 | null | null | null | null | null | <2 mo. follow-up | 3.09082 |
6,264 | 41.435 | 1 | female | 0 | 7 | 41 | MOSF w/Malig | ARF/MOSF | 3 | 11 | under $11k | 0 | 7,838 | 5,635.4297 | 5,671.03906 | 12 | black | 27.597656 | 62 | 0.61792 | 0.512939 | 3 | 1 | 0 | yes | 0.6 | 0.3 | no dnr | 7 | 109 | 44.898438 | 116 | 28 | 36.39844 | 309.9375 | 2.299805 | 0.5 | 1.699951 | 130 | 7.519531 | null | null | null | 0 | 3 | <2 mo. follow-up | 3 |
6,265 | 80.18298 | 1 | male | 1 | 13 | 13 | Coma | Coma | 2 | 12 | under $11k | 100 | 36,723 | 29,460.5938 | 27,187.2812 | 41 | white | 36 | 74 | 0 | 0 | 6 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 1 | 47 | 32 | 120 | 40 | 38.89844 | 163.3125 | 1.799805 | 0.5 | 0.699951 | 138 | 7.40918 | null | null | null | null | null | <2 mo. follow-up | 3.995117 |
6,266 | 69.57697 | 1 | female | 0 | 9 | 320 | Cirrhosis | COPD/CHF/Cirrhosis | 5 | 11 | $11-$25k | 0 | 8,347 | 5,874.9531 | 6,546.91797 | 10.5 | white | 24.699219 | 42 | 0.631958 | 0.448975 | 1 | 1 | 0 | no | 0.5 | 0.4 | no dnr | 9 | 73 | 11.398438 | 82 | 21 | 36.5 | 404.75 | 2.5 | 2.899902 | 2.399902 | 130 | 7.40918 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
6,267 | 74.95398 | 1 | male | 0 | 4 | 24 | CHF | COPD/CHF/Cirrhosis | 2 | 16 | $11-$25k | 0 | 2,309 | 1,776.9834 | 1,674.87988 | 20 | white | 18.898438 | 27 | 0.843994 | 0.743896 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 4 | 97 | 9.099609 | 68 | 20 | 36 | null | 3.599609 | 0.699951 | 2.099609 | 137 | null | null | null | null | 5 | 5 | <2 mo. follow-up | 5 |
6,268 | 51.81897 | 0 | female | 0 | 19 | 1,690 | CHF | COPD/CHF/Cirrhosis | 5 | 11 | $11-$25k | 0 | 28,809 | 22,083.4062 | 22,570.4375 | 17 | white | 20.796875 | 36 | 0.887939 | 0.812988 | 1 | 1 | 0 | no | 0.95 | 0.95 | no dnr | 19 | 77 | 8.099609 | 71 | 24 | 36.79688 | 258.9375 | 3.399902 | 0.299988 | 3.799805 | 136 | 7.399414 | null | null | null | 1 | 1 | no(M2 and SIP pres) | 1 |
6,269 | 41.24298 | 0 | female | 0 | 6 | 1,690 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | under $11k | 0 | 10,551 | 8,130.5781 | 7,272 | 20 | black | 16.398438 | 17 | 0.935913 | 0.891968 | 1 | 1 | 0 | no | 0.85 | 0.8 | no dnr | 6 | 128 | 19.5 | 131 | 20 | 38.59375 | 404 | 4.099609 | 0.899902 | 1 | 137 | 7.339844 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
6,270 | 68.04095 | 1 | female | 1 | 3 | 3 | Coma | Coma | 2 | null | under $11k | 44 | 8,269 | 6,074.5156 | 5,759.40625 | 62 | white | 53.5 | 91 | 0 | 0 | 2 | 0 | 1 | no | null | null | no dnr | 3 | 33 | 14.199219 | 34 | 32 | 36.29688 | 98.32812 | 2.399902 | 2 | 2.199707 | 135 | 6.969727 | null | null | null | null | null | <2 mo. follow-up | 4.039063 |
6,271 | 60.95297 | 0 | male | 0 | 26 | 1,689 | COPD | COPD/CHF/Cirrhosis | 1 | 9 | under $11k | 0 | 53,324 | 40,835.4688 | 37,902.3438 | 32.5 | white | 27.398438 | 26 | 0.793945 | 0.667969 | 1 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 26 | 110 | 10.398438 | 133 | 12 | 38.69531 | 120 | 2.799805 | 0.5 | 1.299805 | 138 | 7.449219 | null | null | null | null | 4 | no(M2 and SIP pres) | 4 |
6,272 | 42.75198 | 1 | male | 0 | 22 | 1,090 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 9 | null | 9 | 27,695 | 22,400.5781 | 21,607.7656 | 19.666656 | white | 22.398438 | 44 | 0.869995 | 0.824951 | 1 | 1 | 0 | no | 0.9 | 0.75 | no dnr | 22 | 137 | 12.699219 | 68 | 24 | 36 | 296.25 | 1.599854 | 0.399963 | 6.199219 | 139 | 7.339844 | null | null | null | null | 7 | adl>=4 (>=5 if sur) | 7 |
6,273 | 56.01898 | 0 | female | 0 | 6 | 1,689 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 5 | under $11k | 0 | 8,783 | 6,218.5195 | 5,969.65625 | 30 | black | 20.097656 | 16 | 0.876953 | 0.833984 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 6 | 104 | 23.398438 | 108 | 30 | 37.79688 | 240 | 2.799805 | 0.599976 | 0.799927 | 139 | 7.389648 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
6,274 | 64.53699 | 1 | male | 0 | 12 | 68 | CHF | COPD/CHF/Cirrhosis | 1 | 9 | $11-$25k | 0 | 23,592 | 18,083.8438 | 17,361.2656 | 22 | white | 35.695313 | 38 | 0.495972 | 0.294983 | 10 | 0 | 0 | no | 0.7 | 0.5 | dnr after sadm | 3 | 67 | 11 | 111 | 22 | 35 | 235.53125 | 3 | 2.699707 | 0.899902 | 121 | 7.469727 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
6,275 | 64.73895 | 1 | male | 0 | 10 | 17 | Lung Cancer | Cancer | 2 | 9 | under $11k | 0 | 7,838 | 5,817.9648 | 5,694.91797 | 7.5 | other | 26.296875 | 31 | 0.47998 | 0.161987 | 1 | 0 | 0 | metastatic | 0.3 | 0.15 | no dnr | 10 | 67 | 32.898438 | 94 | 28 | 35.79688 | null | 3.299805 | 0.299988 | 0.699951 | 132 | null | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
6,276 | 59.02499 | 1 | male | 0 | 4 | 1,312 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 3,383 | 2,272.8789 | 2,304.74805 | 9 | white | 17.5 | 23 | 0.907959 | 0.844971 | 1 | 0 | 0 | no | 0.9 | 0.85 | no dnr | 4 | 82 | 6.699219 | 83 | 22 | 36.39844 | 204.15625 | null | 0.699951 | 0.599976 | 136 | 7.419922 | null | null | null | 1 | null | no(M2 and SIP pres) | 1.1669 |
6,277 | 81.87 | 1 | male | 1 | 4 | 4 | MOSF w/Malig | ARF/MOSF | 4 | null | under $11k | 9 | 9,502 | 6,618.2266 | 7,000.88672 | 20 | white | 26.796875 | 44 | 0.399963 | 0.280945 | 7 | 0 | 0 | metastatic | null | null | dnr after sadm | 3 | 103 | 15.898438 | 116 | 32 | 36.19531 | 175.90625 | 3.299805 | 1 | 1.199951 | 146 | 7.389648 | null | null | null | null | null | <2 mo. follow-up | 4.258789 |
6,278 | 20.99399 | 0 | male | 0 | 9 | 1,682 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | $25-$50k | 0 | 12,648 | 9,978.9609 | 8,982.57812 | 27.5 | white | 22.199219 | 24 | 0.92395 | 0.896973 | 1 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 9 | 109 | 6.199219 | 113 | 48 | 38.89844 | 251.96875 | 2.599609 | 0.199982 | 0.699951 | 145 | 7.319336 | null | null | null | 6 | 6 | adl>=4 (>=5 if sur) | 6 |
6,279 | 58.409 | 1 | male | 0 | 31 | 33 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | null | 44 | 46,172 | 32,606.9531 | 31,291.5938 | 33 | white | 36 | 50 | 0.131989 | 0.059998 | 10 | 0 | 0 | metastatic | 0.75 | 0.422 | dnr after sadm | 14 | 54 | 19.5 | 120 | 8 | 36.19531 | 173.3125 | null | null | 3 | 134 | 7.389648 | null | null | null | null | null | <2 mo. follow-up | 4.379883 |
6,280 | 39.48798 | 1 | female | 1 | 112 | 112 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 44 | 321,392 | 262,124.25 | 243,071.875 | 52 | black | 28.5 | 57 | 0.700928 | 0.611938 | 1 | 1 | 0 | no | 0.5 | 0.5 | no dnr | 112 | 67 | 8.099609 | 122 | 31 | 36.5 | 118.32812 | 2 | 0.399963 | 1.599854 | 150 | 7.449219 | null | null | null | null | 5 | adl>=4 (>=5 if sur) | 5 |
6,281 | 62.66898 | 0 | female | 0 | 4 | 1,677 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 4,871 | 4,022.8203 | 3,836.82812 | 17 | hispanic | 13.398438 | 19 | 0.899902 | 0.832886 | 1 | 0 | 0 | yes | 0.99 | 0.98 | no dnr | 4 | 79 | 7.199219 | 101 | 18 | 36 | 309.5 | 4.399414 | 0.799927 | 0.799927 | 135 | 7.469727 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
6,282 | 73.36597 | 1 | male | 1 | 19 | 19 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 12 | under $11k | 9 | 33,368 | 24,966.2656 | 24,285.7188 | 31.666656 | white | 28.5 | 41 | 0.525879 | 0.41095 | 5 | 1 | 0 | yes | 0.7 | 0.6 | dnr after sadm | 14 | 66 | 11.099609 | 109 | 24 | 36.09375 | 210 | 2.5 | 1.5 | 5.699219 | 136 | 7.419922 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
6,283 | 78.71295 | 1 | female | 0 | 5 | 1,029 | COPD | COPD/CHF/Cirrhosis | 1 | 7 | under $11k | 0 | 3,584 | 2,589.7754 | 2,489.69922 | 9 | white | 14.798828 | 16 | 0.85791 | 0.765991 | 1 | 0 | 0 | no | 0.9 | 0.75 | dnr after sadm | 2 | 92 | 6.699219 | 64 | 24 | 36.29688 | 250 | 3.699707 | 0.299988 | 0.699951 | 140 | 7.339844 | null | null | null | null | null | SIP>=30 | 2.572266 |
6,284 | 63.54797 | 1 | male | 0 | 7 | 647 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | $11-$25k | 0 | 7,074 | 5,695.9258 | 5,477.97656 | 9.5 | white | 13.298828 | 22 | 0.919922 | 0.863892 | 1 | 1 | 0 | no | 0.5 | 0.5 | no dnr | 7 | 72 | 7.399414 | 76 | 24 | 38.19531 | 252 | 3.599609 | 1.599854 | 1.099854 | 133 | 7.449219 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
6,285 | 67.59998 | 1 | female | 1 | 14 | 14 | Coma | Coma | 0 | 14 | under $11k | 44 | 37,827 | 25,447.2344 | 25,528.6719 | 35.666657 | white | 25.898438 | 25 | 0.32196 | 0.25 | 7 | 0 | 0 | no | 1 | 1 | dnr after sadm | 11 | 124 | 21.199219 | 118 | 24 | 38.5 | 290 | 4.699219 | 0.5 | 0.599976 | 127 | 7.579102 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
6,286 | 73.98499 | 1 | male | 0 | 18 | 31 | Lung Cancer | Cancer | 1 | 12 | under $11k | 26 | 17,861 | 12,884.8359 | 14,661.5078 | 9.666664 | white | 24.597656 | 13 | 0.363953 | 0.081985 | 1 | 0 | 0 | metastatic | 0.9 | 0.6 | no dnr | 18 | 101 | 6.5 | 98 | 24 | 36.89844 | null | 2.799805 | 0.699951 | 0.699951 | 136 | null | null | null | null | null | 0 | <2 mo. follow-up | 0 |
6,287 | 42.25299 | 1 | male | 0 | 8 | 122 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 0 | under $11k | 0 | 6,724 | 4,834.4141 | 4,777.33984 | 5 | white | 16.597656 | 10 | 0.900879 | 0.833984 | 1 | 0 | 0 | no | 0.8 | 0.5 | no dnr | 8 | 112 | 3.699707 | 104 | 20 | 37.59375 | null | 2.5 | 0.799927 | 0.699951 | 138 | null | null | null | null | null | 6 | adl>=4 (>=5 if sur) | 6 |
6,288 | 68.04395 | 0 | male | 0 | 20 | 1,670 | MOSF w/Malig | ARF/MOSF | 1 | 12 | $11-$25k | 0 | 22,680 | 16,296.9141 | 16,798.4375 | 14.333328 | white | 29.898438 | 38 | 0.472961 | 0.353943 | 1 | 0 | 0 | metastatic | 0.7 | 0.5 | no dnr | 20 | 64 | 4.699219 | 144 | 24 | 35.59375 | null | 2.299805 | 0.299988 | 0.399963 | 131 | null | null | null | null | 0 | 0 | SIP>=30 | 0 |
6,289 | 60.56699 | 0 | female | 0 | 3 | 1,670 | Cirrhosis | COPD/CHF/Cirrhosis | 6 | 10 | under $11k | 0 | 2,917 | 2,180.8457 | 2,257.1582 | 9 | white | 14.398438 | 20 | 0.859985 | 0.768921 | 1 | 1 | 0 | no | null | null | no dnr | 3 | 87 | 6.599609 | 87 | 20 | 36.69531 | null | 2.399902 | 1.299805 | 1.199951 | 137 | null | null | null | null | null | null | no(M2 and SIP pres) | 3.04834 |
6,290 | 49.13098 | 1 | female | 0 | 12 | 945 | MOSF w/Malig | ARF/MOSF | 1 | 12 | >$50k | 0 | 36,857 | 27,530.7656 | 29,273.5469 | 21.5 | white | 30.597656 | 23 | 0.362976 | 0.244995 | 21 | 0 | 0 | metastatic | 0.65 | 0.5 | no dnr | 12 | 102 | 1.299805 | 126 | 22 | 38.5 | null | null | null | 0.5 | 131 | null | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
6,291 | 50.32397 | 1 | female | 1 | 27 | 27 | COPD | COPD/CHF/Cirrhosis | 2 | null | null | 9 | 70,501 | 59,879.0938 | 54,732.3438 | 38.25 | white | 20.898438 | 21 | 0.898926 | 0.829956 | 1 | 0 | 0 | no | 0.6 | 0.5 | dnr after sadm | 21 | 69 | 10.298828 | 131 | 10 | 38.39844 | 197.125 | 3.099609 | 0.399963 | 1.099854 | 132 | 7.349609 | null | null | null | null | null | <2 mo. follow-up | 3.070313 |
6,292 | 45.69699 | 1 | female | 0 | 5 | 355 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 4,335 | 3,087.1445 | 3,103.14844 | 13 | black | 15 | 24 | 0.93689 | 0.892944 | 1 | 1 | 0 | no | null | null | no dnr | 5 | 69 | 5.5 | 78 | 18 | 36.59375 | 400 | 3.699707 | 0.199982 | 1.899902 | 142 | 7.419922 | null | null | null | null | null | no(M2 and SIP pres) | 2.254395 |
6,293 | 62.689 | 1 | female | 1 | 16 | 16 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 15 | $25-$50k | 44 | 87,477 | 59,774.2812 | 58,683.6875 | 37.666657 | white | 39.59375 | 45 | 0.039993 | 0.011999 | 36 | 0 | 0 | metastatic | 0 | 0 | no dnr | 16 | 112 | 17.199219 | 117 | 27 | 38.69531 | 89.85938 | 2.099609 | 5.599609 | 0.599976 | 128 | 7.449219 | null | null | null | null | 4 | <2 mo. follow-up | 4 |
6,294 | 72.98297 | 1 | female | 0 | 4 | 880 | CHF | COPD/CHF/Cirrhosis | 5 | 7 | under $11k | 0 | 3,225 | 2,338.6484 | 2,259.18945 | 4 | black | 18.699219 | 40 | 0.815918 | 0.700928 | 1 | 1 | 0 | yes | 0.95 | 0.75 | no dnr | 4 | 103 | 5.799805 | 65 | 20 | 36.19531 | 366.1875 | 3.899902 | 0.399963 | 6.599609 | 135 | 7.389648 | null | null | null | 1 | null | null | 1.1669 |
6,295 | 87.55597 | 1 | female | 0 | 9 | 509 | CHF | COPD/CHF/Cirrhosis | 3 | 8 | $11-$25k | 0 | 5,840 | 4,547.3086 | 4,396.90625 | 7.5 | white | 15.398438 | 18 | 0.806885 | 0.688965 | 1 | 0 | 0 | yes | 0.95 | 0.7 | dnr after sadm | 3 | 110 | 6.799805 | 96 | 24 | 36.09375 | null | 3.699707 | 0.899902 | 1.099854 | 142 | null | null | null | null | 5 | 6 | SIP>=30 | 6 |
6,296 | 48.30399 | 1 | female | 0 | 7 | 116 | Colon Cancer | Cancer | 1 | 14 | $11-$25k | 0 | 6,058 | 4,324.293 | 4,846.14844 | 9 | black | 37.5 | 35 | 0.411987 | 0.110992 | 1 | 0 | 0 | metastatic | 0.2 | 0.05 | no dnr | 7 | 96 | 16.296875 | 122 | 24 | 39.19531 | 442.8125 | 2.699707 | 9.898438 | 0.399963 | 132 | 7.449219 | null | null | null | 1 | 1 | no(M2 and SIP pres) | 1 |
6,297 | 68.39197 | 1 | male | 1 | 5 | 5 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 11 | null | 9 | 16,055 | 12,093.0312 | 13,168.2734 | 46 | white | 23.5 | 55 | 0.633911 | 0.451965 | 1 | 1 | 0 | no | 0.1 | 0.001 | no dnr | 5 | 108 | 9.798828 | 71 | 12 | 36.29688 | 380.375 | 1.799805 | 2.399902 | 1.899902 | 131 | 7.449219 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
6,298 | 49.93597 | 1 | male | 0 | 7 | 97 | Lung Cancer | Cancer | 1 | 18 | >$50k | 0 | 11,273 | 8,660.2344 | 9,122.01562 | 18 | white | 24.5 | 12 | 0.577881 | 0.256958 | 1 | 0 | 0 | metastatic | 0.4 | 0.2 | no dnr | 7 | 73 | 3.5 | 104 | 22 | 36.19531 | null | 3.099609 | 0.299988 | 0.5 | 136 | null | null | null | null | 5 | 5 | SIP>=30 | 5 |
6,299 | 71.461 | 1 | male | 1 | 6 | 6 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 0 | 42,908 | 31,028.6406 | 31,654.4375 | 54 | white | 34 | 45 | 0.335999 | 0.219971 | 8 | 0 | 0 | yes | 0.75 | 0.5 | no dnr | 6 | 67 | 17.097656 | 117 | 12 | 36.19531 | 132.28125 | null | null | 3.399902 | 138 | 7.5 | null | null | null | null | null | <2 mo. follow-up | 2.437988 |
6,300 | 63.46298 | 1 | male | 1 | 20 | 20 | Lung Cancer | Cancer | 2 | 11 | $11-$25k | 0 | 18,784 | 15,695.4219 | 15,219.2969 | 16.666656 | white | 24.296875 | 35 | 0.540894 | 0.218994 | 1 | 0 | 0 | metastatic | 0.8 | 0.4 | dnr after sadm | 7 | 68 | 10.798828 | 120 | 32 | 36.29688 | 276.1875 | null | 0.699951 | 0.799927 | 132 | 7.5 | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.